COMPARATIVE STUDY ON ANTIOXIDANT ACTIVITY OF SALVIA NEMOROSA L. FROM TWO DIFFERENT LOCATIONS
In order to investigate the antioxidant activity of Salvia nemorosa L. collected from Ahar and Urmia regionsin Iran at different growth stages, aerial parts of sage after collecting were dried, and for measurement, the abilityof scavenge DPPH (2,2-diphenyl-1-picryl-hydrazyl-hydrate) radical in different concentrations (0.025, 0.05, 0.07,0.1, 0.2, 0.04 and 0.6) of methanolic extracts were prepared. The result showed that the ability to scavenge DPPHradical and amount of inhibition percent of vegetative stage leaves, flowering stage leaves, and flowers increasedwith increasing concentrations of methanolic extracts from 0.25 to 0.6 mg/mL. In the region of Urmia, the highestamount of DPPH inhibition there was in vegetative stage leaves, and the lowest amount of DPPH inhibition wasseen in flowers. In Ahar regions, unlike the Urmia region, the highest amount of DPPH inhibition there was inflowers, but the lowest of DPPH inhibition was seen in flowering stage leaves. Also, the content of inhibition ofDPPH in Ahar and Urmia regions similarly increased between two phenological stages (vegetative stage leaves,flowering stage leaves, and flowers) in 0.4 mg/mL and 0.6 mg/mL concentrations.
Read ArticleTYPE 2 DIABETES MELLITUS EFFECTS ON SEMEN PARAMETERS AND SEMINAL PLASMA
Background: Diabetes Type 2 is a complex disorder described by an imbalance between insulin resistance and secretion that induce liver glucose output. It has been shown that serum insulin levels are affected by a sperm plasma membrane and acrosome. Therefore, during insulin resistance spermatogenesis changes, diabetic patients detect testicular changes. Aims: This research aims to know the effect of diabetic type 2 on some aspects of fertility in men by studying the characteristics of the semen and some biochemical parameters in seminal plasma. Methods: This study was achieved at the Center for Endocrinology and Diabetes Specialists in Maysan province from February to November 2018 and included 45 men (30 diabetic and 15 healthy in the control group) aged 30 to 59 years. The patients were divided according to age into two groups, the first (30-39) and second (40-59) years, also divided by the duration of diabetes into two groups, the first (1-5) and second (6-10) year. Results: The pH of semen in the second age group (40-49 years) group and first duration (1-5 years) group were significantly decreased (P <0.05) in diabetes compared with the control group. Volume and viscosity did not have significant differences in patients compared to the control following the age and duration of diabetes. Liquefaction only in the first age (30-39 years) group significantly increased (P <0.05) compared to the control. The concentration of sperm, progressive motility, non-progressive and normal morphology decreased (P <0.05) significantly. While the sluggish, dead, and abnormal morphology significantly increased (P <0.05) in all diabetes groups compared with the control. The fructose and alkaline phosphatase values in the seminal plasma were not differing significantly in patients compared with the control. Zinc and glutathione values decreased significantly (P <0.05) compared with control in each age and duration of diabetes. Discussion: Insulin stimulates the Ledying cell function, defect insulin effect on spermatogenesis. Impaired sperm motility in a patient with D.M. might be attributed to many reasons, such as increased ROS level, altered mitochondria DNA, and decreased epididymal products. Conclusion: our measurement indicates that there is an effect of type 2 diabetes mellitus on semen parameters and seminal plasma biochemical parameters.
Read ArticleHIGH BURDEN OF VITAMIN D DEFICIENCY AND FERRITIN-LINKED IMPACT IN Β-THALASSEMIA MAJOR
Background: Background: Vitamin D plays an essential role in bone health and overall physiological function, and its deficiency is common in children and adolescents with β-thalassemia major (βTM). Iron overload, as reflected by elevated ferritin, may further influence vitamin D status. Aim: This study aimed to evaluate serum vitamin D levels in βTM patients and determine their association with ferritin levels. Methods: A total of 40 βTM patients and 20 age-matched healthy controls (aged 4–25 years) were enrolled between October 2024 and February 2025. Serum vitamin D, calcium, ferritin, and hemoglobin were measured. Statistical analysis, including correlation and logistic regression, was performed using SPSS v.26 to identify predictors of vitamin D deficiency. Results: Vitamin D deficiency was highly prevalent among βTM patients (70%) compared with controls. Patients showed significantly lower vitamin D levels (17.32±1.56) than controls (25.34±1.76). Vitamin D levels were positively correlated with age (r = 0.788), calcium (r = 0.772), and hemoglobin (r = 0.771), and negatively correlated with ferritin (r = −0.517). Logistic regression demonstrated that ferritin >1000 ng/mL strongly predicted vitamin D deficiency (OR = 17.875; 95% CI: 3.258–98.074; p = 0.001), while younger age ( < 10 years) also increased the odds of deficiency (OR = 5.200; p = 0.018). Discussion: D deficiency is a prevalent and intrinsic metabolic disturbance in β-thalassemia major, closely linked to chronic iron overload and elevated ferritin levels. This interplay disrupts hepatic vitamin D hydroxylation, induces inflammation, and contributes to endocrine and skeletal complications, highlighting ferritin as a key predictor of deficiency in these patients. Conclusion: Vitamin D deficiency is highly prevalent in βTM and is strongly associated with elevated ferritin levels, suggesting that iron overload is a significant predictor. Integrating vitamin D assessment into routine monitoring may support better management of disease-related metabolic disturbances in patients with βTM.
Read Article